Avista Corp. <AVA.N>: Barclays cuts target price to $37 from $40
AVA•Related News
Xometry Q2 Adjusted EBITDA USD 14.143 Million Vs. IBES Estimate USD 11.7 Million
XMTR•
McDonald's US sales disappoint as value deals fail to draw enough diners
MCD•
Beam Therapeutics Q2 FY26 net loss widens to $122.7 million; revenue drops to $490,000
BEAM•
Westlake Chemical Partners' Q2 net income dips
WLKP•
Datadog Inc <DDOG.O>: Rosenblatt Securities raises target price to $305 from $220
DDOG•